Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 7843584, 9 pages
https://doi.org/10.1155/2017/7843584
Research Article

Protein Array-Based Detection of Proteins in Kidney Tissues from Patients with Membranous Nephropathy

Department of Nephrology, PLA General Hospital, Institute of Nephrology, Beijing Key Laboratory of Kidney Disease, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing 100853, China

Correspondence should be addressed to Di Wu; nc.moc.latipsoh103@iduw

Received 19 November 2016; Revised 25 January 2017; Accepted 29 January 2017; Published 27 February 2017

Academic Editor: Gang Liu

Copyright © 2017 Shuqiang Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Dahan, “Membranous nephropathy: diagnosis, new insights in pathophysiology, and therapeutic approach,” La Revue de Médecine Interne, vol. 37, no. 10, pp. 674–679, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Bally, H. Debiec, D. Ponard et al., “Phospholipase A2 receptor-related membranous nephropathy and mannan-binding lectin deficiency,” Journal of the American Society of Nephrology, vol. 27, no. 12, pp. 3539–3544, 2016. View at Publisher · View at Google Scholar
  3. L. H. Beck Jr., R. G. B. Bonegio, G. Lambeau et al., “M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy,” New England Journal of Medicine, vol. 361, no. 1, pp. 11–21, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. D.-B. Borza, “Alternative pathway dysregulation and the conundrum of complement activation by IgG4 immune complexes in membranous nephropathy,” Frontiers in Immunology, vol. 7, article no. 157, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Borza, “Glomerular basement membrane heparan sulfate in health and disease: a regulator of local complement activation,” Matrix Biology, 2016. View at Publisher · View at Google Scholar
  6. R. A. Sinico, N. Mezzina, B. Trezzi, G. M. Ghiggeri, and A. Radice, “Immunology of membranous nephropathy: from animal models to humans,” Clinical and Experimental Immunology, vol. 183, no. 2, pp. 157–165, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. H. S. Lee, “Mechanisms and consequences of TGF-β overexpression by podocytes in progressive podocyte disease,” Cell and Tissue Research, vol. 347, no. 1, pp. 129–140, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. H. S. Lee, “Pathogenic role of TGF-ß in the progression of podocyte diseases,” Histology and Histopathology, vol. 26, no. 1, pp. 107–116, 2011. View at Google Scholar · View at Scopus
  9. M. Nangaku, S. J. Shankland, and W. G. Couser, “Cellular response to injury in membranous nephropathy,” Journal of the American Society of Nephrology, vol. 16, no. 5, pp. 1195–1204, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Sutariya, D. Jhonsa, and M. N. Saraf, “TGF-β: the connecting link between nephropathy and fibrosis,” Immunopharmacology and Immunotoxicology, vol. 38, no. 1, pp. 39–49, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Bantis, P. J. Heering, S. Aker et al., “Tumor necrosis factor-α gene G-308A polymorphism is a risk factor for the development of membranous glomerulonephritis,” American Journal of Nephrology, vol. 26, no. 1, pp. 12–15, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Kalavrizioti, M. Gerolymos, M. Rodi et al., “T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: can they predict outcome?” Cytokine, vol. 76, no. 2, pp. 260–269, 2015. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Thibaudin, L. Thibaudin, P. Berthoux et al., “TNFA2 and d2 alleles of the tumor necrosis factor alpha gene polymorphism are associated with onset/occurrence of idiopathic membranous nephropathy,” Kidney International, vol. 71, no. 5, pp. 431–437, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Valentina, F. Jan, N. L. Peder, Z. Bo, D. Hongjie, and K. Pernille, “Cytokine detection and simultaneous assessment of rheumatoid factor interference in human serum and synovial fluid using high-sensitivity protein arrays on plasmonic gold chips,” BMC Biotechnology, vol. 15, no. 1, article no. 73, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. P. V. Hauser, P. Perco, I. Mühlberger et al., “Microarray and bioinformatics analysis of gene expression in experimental membranous nephropathy,” Nephron—Experimental Nephrology, vol. 112, no. 2, pp. e43–e58, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Lee, Y.-T. Ahn, J.-H. Lee, C.-S. Huh, and D.-H. Kim, “Evaluation of anti-colitic effect of lactic acid bacteria in mice by cDNA microarray analysis,” Inflammation, vol. 32, no. 6, pp. 379–386, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. K. M. Sepuru, B. Nagarajan, U. R. Desai, and K. Rajarathnam, “Molecular basis of chemokine CXCL5-glycosaminoglycan interactions,” Journal of Biological Chemistry, vol. 291, no. 39, pp. 20539–20550, 2016. View at Publisher · View at Google Scholar
  18. W. L. Lai, T. H. Yeh, P. M. Chen et al., “Membranous nephropathy: a review on the pathogenesis, diagnosis, and treatment,” Journal of the Formosan Medical Association, vol. 114, no. 2, pp. 102–111, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Sakamaki, H. Sasamura, K. Hayashi et al., “Absence of gelatinase (MMP-9) or collagenase (MMP-13) attenuates adriamycin-Induced albuminuria and glomerulosclerosis,” Nephron—Experimental Nephrology, vol. 115, no. 2, pp. e22–e32, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. E. Campbell, A. Sood, D. J. Argyle, L. Nasir, S. A. Argyle, and D. Bennett, “The cloning and functional analysis of canine matrix metalloproteinase-13 gene promoter,” Gene, vol. 286, no. 2, pp. 233–240, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Wang, X. Tong, X. Jiang, and F. Yang, “Effect of matrix metalloproteinase-mediated matrix degradation on glioblastoma cell behavior in 3D PEG-based hydrogels,” Journal of Biomedical Materials Research Part A, vol. 105, no. 3, pp. 770–778, 2017. View at Publisher · View at Google Scholar
  22. E. Ha and K. C. Mun, “Effects of cyclosporine on metalloproteinase in endothelial cells,” Transplantation Proceedings, vol. 44, no. 4, pp. 991–992, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. C. Deltas, A. Pierides, and K. Voskarides, “Molecular genetics of familial hematuric diseases,” Nephrology Dialysis Transplantation, vol. 28, no. 12, pp. 2946–2960, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Herbach, I. Schairer, A. Blutke et al., “Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis,” American Journal of Physiology—Renal Physiology, vol. 296, no. 4, pp. F819–F829, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. L. Alvarez, M. Khosroheidari, E. Eddy, and J. Kiefer, “Role of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy,” PLoS ONE, vol. 8, no. 10, Article ID e77468, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Yurube, T. Takada, T. Suzuki et al., “Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration,” Arthritis Research and Therapy, vol. 14, no. 2, article no. R51, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Fox, P. Cocchiaro, F. Oakley et al., “Inhibition of lysosomal protease cathepsin D reduces renal fibrosis in murine chronic kidney disease,” Scientific Reports, vol. 6, Article ID 20101, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. A. B. Singh and R. C. Harris, “Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells,” The Journal of Biological Chemistry, vol. 279, no. 5, pp. 3543–3552, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Škoberne, A. Behnert, B. Teng et al., “Serum with phospholipase A2 receptor autoantibodies interferes with podocyte adhesion to collagen,” European Journal of Clinical Investigation, vol. 44, no. 8, pp. 753–765, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Zheng, L.-L. Lv, Y.-H. Cao et al., “A pilot trial assessing urinary gene expression profiling with an mRNA array for diabetic nephropathy,” PLoS ONE, vol. 7, no. 5, Article ID e34824, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Ritz, M.-L. Gross, and R. Dikow, “Role of calcium-phosphorous disorders in the progression of renal failure,” Kidney International. Supplement, no. 99, pp. S66–S70, 2005. View at Google Scholar · View at Scopus
  32. S. P. McAdoo, G. Bhangal, T. Page, H. T. Cook, C. D. Pusey, and F. W. K. Tam, “Correlation of disease activity in proliferative glomerulonephritis with glomerular spleen tyrosine kinase expression,” Kidney International, vol. 88, no. 1, pp. 52–60, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Tamouza, J. M. Chemouny, L. Raskova Kafkova et al., “The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy,” Kidney International, vol. 82, no. 12, pp. 1284–1296, 2012. View at Publisher · View at Google Scholar · View at Scopus